The Pacific experience: supporting small island countries and territories to meet their 2012 International Health Regulations (2005) commitments: Short title: The Pacific experienc...

Por Craig, Adam, Kool, Jacob, Nilles, Eric
Publicado em 2013

Commentary: Zika Virus: the Latest Newcomer

Por Craig, Adam T., Paterson, Beverley J., Durrheim, David N.
Publicado no Front Microbiol (2016)

Acute flaccid paralysis incidence and Zika virus surveillance, Pacific Islands

Por Craig, Adam T, Butler, Michelle T, Pastore, Roberta, Paterson, Beverley J, Durrheim, David N
Publicado no Bull World Health Organ (2017)

Risk posed by the Ebola epidemic to the Pacific islands: findings of a recent World Health Organization assessment

Por Craig, Adam T, Ronsse, Axelle, Hardie, Kate, Pavlin, Boris I, Biaukula, Viema, Nilles, Eric J
Publicado no Western Pac Surveill Response J (2015)

DAY NEUTRAL FLOWERING Represses CONSTANS to Prevent Arabidopsis Flowering Early in Short Days([W])([OA])

Por Morris, Karl, Thornber, Sarah, Codrai, Lesley, Richardson, Christine, Craig, Adam, Sadanandom, Ari, Thomas, Brian, Jackson, Stephen
Publicado em 2010

Towards effective outbreak detection: a qualitative study to identify factors affecting nurses’ early warning surveillance practice in Solomon Islands

Por Craig, Adam T., Joshua, Cynthia A., Sio, Alison R., Lauri, Michael, Kaldor, John, Rosewell, Alexander E., Schierhout, Gill
Publicado no BMC Health Serv Res (2018)

Response to a large rotavirus outbreak on South Tarawa, Kiribati, 2013

Por Tabunga, Teanibuaka, Utiera, Maryanne, Tekoaua, Rosemary, Tibwe, Tebikau, Tira, Teatao, Toatu, Tebuka, Duituturaga, Sala Elbourne, Nilles, Eric, Craig, Adam
Publicado em 2014

Enhanced surveillance during a public health emergency in a resource-limited setting: Experience from a large dengue outbreak in Solomon Islands, 2016-17

Por Craig, Adam T., Joshua, Cynthia A., Sio, Alison R., Teobasi, Bobby, Dofai, Alfred, Dalipanda, Tenneth, Hardie, Kate, Kaldor, John, Kolbe, Anthony
Publicado no PLoS One (2018)

Pharmacokinetic study of omacetaxine mepesuccinate administered subcutaneously to patients with advanced solid and hematologic tumors

Por Nemunaitis, John, Mita, Alain, Stephenson, Joe, Mita, Monica M., Sarantopoulos, John, Padmanabhan-Iyer, Swami, Nanda, Nisha, Gleich, Lyon, Benichou, Annie-Claude, Craig, Adam
Publicado em 2012

Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors

Por Nicolini, Franck E., Khoury, H. Jean, Akard, Luke, Rea, Delphine, Kantarjian, Hagop, Baccarani, Michele, Leonoudakis, Janis, Craig, Adam, Benichou, Annie-Claude, Cortes, Jorge
Publicado em 2013

Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation

Por Cortes, Jorge, Lipton, Jeff H., Rea, Delphine, Digumarti, Raghunadharao, Chuah, Charles, Nanda, Nisha, Benichou, Annie-Claude, Craig, Adam R., Michallet, Mauricette, Nicolini, Franck E., Kantarjian, Hagop
Publicado no Blood (2012)

Subcutaneous Omacetaxine Mepesuccinate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With 2 or More Tyrosine Kinase Inhibitors Including Imatinib

Por Cortes, Jorge E., Nicolini, Franck E., Wetzler, Meir, Lipton, Jeffrey H., Akard, Luke, Craig, Adam, Nanda, Nisha, Benichou, Annie-Claude, Leonoudakis, Janis, Khoury, H. Jean, Hochhaus, Andreas, Baccarani, Michele, Kantarjian, Hagop M.
Publicado em 2013

BTB-BACK Domain Protein POB1 Suppresses Immune Cell Death by Targeting Ubiquitin E3 ligase PUB17 for Degradation

Por Orosa, Beatriz, He, Qin, Mesmar, Joelle, Gilroy, Eleanor M., McLellan, Hazel, Yang, Chengwei, Craig, Adam, Bailey, Mark, Zhang, Cunjin, Moore, Jonathan David, Boevink, Petra C., Tian, Zhendong, Birch, Paul R. J., Sadanandom, Ari
Publicado no PLoS Genet (2017)

A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemia

Por Lancet, Jeffrey E., Roboz, Gail J., Cripe, Larry D., Michelson, Glenn C., Fox, Judith A., Leavitt, Richard D., Chen, Tianling, Hawtin, Rachael, Craig, Adam R., Ravandi, Farhad, Maris, Michael B., Stuart, Robert K., Karp, Judith E.
Publicado no Haematologica (2015)

Vosaroxin in combination with decitabine in newly diagnosed older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome

Por Daver, Naval, Kantarjian, Hagop, Garcia-Manero, Guillermo, Jabbour, Elias, Borthakur, Gautam, Brandt, Mark, Pierce, Sherry, Vaughan, Kenneth, Ning, Jing, Nogueras González, Graciela M., Patel, Keyur, Jorgensen, Jeffery, Pemmaraju, Naveen, Kadia, Tapan, Konopleva, Marina, Andreeff, Michael, DiNardo, Courtney, Cortes, Jorge, Ward, Renee, Craig, Adam, Ravandi, Farhad
Publicado no Haematologica (2017)

Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, mult...

Por Ravandi, Farhad, Ritchie, Ellen K., Sayar, Hamid, Lancet, Jeffrey E., Craig, Michael D., Vey, Norbert, Strickland, Stephen A., Schiller, Gary J., Jabbour, Elias, Erba, Harry P., Pigneux, Arnaud, Horst, Heinz-August, Recher, Christian, Klimek, Virginia M., Cortes, Jorge, Roboz, Gail J., Odenike, Olatoyosi, Thomas, Xavier, Havelange, Violaine, Maertens, Johan, Derigs, Hans-Günter, Heuser, Michael, Damon, Lloyd, Powell, Bayard L., Gaidano, Gianluca, Carella, Angelo-Michele, Wei, Andrew, Hogge, Donna, Craig, Adam R., Fox, Judith A., Ward, Renee, Smith, Jennifer A., Acton, Gary, Mehta, Cyrus, Stuart, Robert K., Kantarjian, Hagop M.
Publicado no Lancet Oncol (2015)